EcoDrugPlus

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSTTRG00000016410
Gene Symbol: ERBB3
1 Cross references
282 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSTTRG00000010092
Gene Symbol: ERBB4
1 Cross references
236 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSTTRG00000002996
Gene Symbol: ESR1
1 Cross references
211 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSTTRG00000000517
Gene Symbol: ESR2
1 Cross references
273 Possible Orthologues:

Exportin 1

Ensembl ID : ENSTTRG00000013369
Gene Symbol: XPO1
1 Cross references
304 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSTTRG00000013326
Gene Symbol: FDPS
1 Cross references
262 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSTTRG00000011965
Gene Symbol: FDFT1
1 Cross references
215 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSTTRG00000008870
Gene Symbol: FNTA
3 Cross references
216 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSTTRG00000002692
Gene Symbol: FNTB
1 Cross references
210 Possible Orthologues:

Fatty Acid Amide Hydrolase

Ensembl ID : ENSTTRG00000009374
Gene Symbol: FAAH
1 Cross references
131 Possible Orthologues:

Fibroblast Activation Protein Alpha

Ensembl ID : ENSTTRG00000013776
Gene Symbol: FAP
1 Cross references
127 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSTTRG00000004544
Gene Symbol: FGFR1
1 Cross references
289 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).